-
Loading metrics
Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study
-
Yehuda Z. Cohen,
Roles Conceptualization, Data curation, Investigation, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing
Affiliation Laboratory of Molecular Immunology, The Rockefeller University, New York, New York, United States of America
⨯ - Allison L. Butler,
- Katrina Millard,
- Maggi Witmer-Pack,
- Rebeka Levin,
- Cecilia Unson-O’Brien,
- Roshni Patel,
- Irina Shimeliovich,
- Julio C. C. Lorenzi,
- Jill Horowitz,
-
Stephen R. Walsh,
Roles Investigation
Affiliation Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, Massachusetts, United States of America
⨯ - Shu Lin,
- Joshua A. Weiner,
- Anna Tse,
- Alicia Sato,
- Chelsey Bennett,
- Bryan Mayer,
- Kelly E. Seaton,
- Nicole L. Yates,
- Lindsey R. Baden,
- Allan C. deCamp,
- Margaret E. Ackerman,
- Michael S. Seaman,
- Georgia D. Tomaras,
- Michel C. Nussenzweig,
- [ ... ],
- Marina Caskey
- [ view all ]
- [ view less ]
http://orcid.org/0000-0001-6987-1478
Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study
- Yehuda Z. Cohen,
- Allison L. Butler,
- Katrina Millard,
- Maggi Witmer-Pack,
- Rebeka Levin,
- Cecilia Unson-O’Brien,
- Roshni Patel,
- Irina Shimeliovich,
- Julio C. C. Lorenzi,
- Jill Horowitz
x
- Published: August 8, 2019
- https://doi.org/10.1371/journal.pone.0219142